Integrated Wealth Concepts’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$126K Sell
45,200
-5,800
-11% -$19.7K ﹤0.01% 2157
2025
Q4
$187K Sell
51,000
-17,000
-25% -$48.4K ﹤0.01% 1539
2025
Q3
$251K Hold
68,000
﹤0.01% 1736
2025
Q2
$126K Buy
68,000
+8,600
+14% +$14.9K ﹤0.01% 1811
2025
Q1
$92.7K Hold
59,400
﹤0.01% 1680
2024
Q4
$120K Buy
59,400
+13,300
+29% +$24.1K ﹤0.01% 1647
2024
Q3
$66.6K Buy
46,100
+18,700
+68% +$35.6K ﹤0.01% 1631
2024
Q2
$46.9K Buy
27,400
+7,334
+37% +$13.3K ﹤0.01% 1616
2024
Q1
$40.1K Buy
20,066
+10,000
+99% +$19.9K ﹤0.01% 1623
2023
Q4
$30.3K Buy
+10,066
New +$26.6K ﹤0.01% 1573

Other funds holding FBIO

Integrated Wealth Concepts's FBIO Position: Q1 2026 in Review

Integrated Wealth Concepts reduced its Fortress Biotech (FBIO) stake by 11% in Q1 2026, selling an estimated $19.7K and leaving 45,200 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #2157.

Integrated Wealth Concepts first reported a position in FBIO in Q4 2023 and has held it in 10 quarters since. The position peaked at $251K in Q3 2025. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • Integrated Wealth Concepts held 45,200 shares of Fortress Biotech worth $126K as of Q1 2026.
  • Integrated Wealth Concepts sold 5,800 Fortress Biotech shares in Q1 2026, an estimated $19.7K.
  • Fortress Biotech made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q1 2026, its #2157 holding.
  • Integrated Wealth Concepts first reported a position in Fortress Biotech in Q4 2023 and has held it in 10 quarters since.
  • Integrated Wealth Concepts's Fortress Biotech position peaked at $251K in Q3 2025.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.